share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Mar 4 17:47
Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. officer David W. Osborne is set to sell 4,255 shares of common stock on 03/04/2024, as per the latest filing. The shares to be sold were recently acquired through restricted stock vests on three separate dates: 882 shares on 03/03/2024, 2,618 shares on 03/01/2024, and 755 shares on 02/27/2024, all from Arcutis Biotherapeutics. The aggregate market value of the shares to be sold is reported at $47,320.81. There is no transaction history reported for the past three months prior to this notice.
Arcutis Biotherapeutics, Inc. officer David W. Osborne is set to sell 4,255 shares of common stock on 03/04/2024, as per the latest filing. The shares to be sold were recently acquired through restricted stock vests on three separate dates: 882 shares on 03/03/2024, 2,618 shares on 03/01/2024, and 755 shares on 02/27/2024, all from Arcutis Biotherapeutics. The aggregate market value of the shares to be sold is reported at $47,320.81. There is no transaction history reported for the past three months prior to this notice.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more